Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Acq. announced
Appointed director
Notes underwriting agrmnt

Kura Oncology, Inc. (KURA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/16/2023 4 Powl Brian T. (Chief Commercial Officer) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 200,000 options to buy @ $11.72, valued at $2.3M
08/16/2023 3 Powl Brian T. (Chief Commercial Officer) has filed a Form 3 on Kura Oncology, Inc.
06/02/2023 4 WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.
Txns: Disposed of 8,394 shares @ $0
Acquired 8,394 shares @ $0
Disposed of 41,318 shares @ $0
Disposed of 212,500 shares @ $0
Disposed of 300,000 shares @ $0
Acquired 300,000 shares @ $0
Disposed of 27,966 shares @ $0
06/02/2023 4 Szela Mary T (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 26,000 options to buy @ $13.32, valued at $346.3k
06/02/2023 4 SCHAFER CAROL (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 26,000 options to buy @ $13.32, valued at $346.3k
06/02/2023 4 Parks Diane L. (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 26,000 options to buy @ $13.32, valued at $346.3k
06/02/2023 4 Malley Thomas (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 26,000 options to buy @ $13.32, valued at $346.3k
06/02/2023 4 Hasnain Faheem (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 26,000 options to buy @ $13.32, valued at $346.3k
06/02/2023 4 Collins Helen Louise (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 26,000 options to buy @ $13.32, valued at $346.3k
02/21/2023 4 DOYLE THOMAS JAMES (SVP, Finance & Accounting) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 10,625 shares @ $0
Granted 63,750 options to buy @ $11.99, valued at $764.4k
02/21/2023 4 Bair Teresa Brophy (Chief Legal Officer) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 23,125 shares @ $0
Granted 138,750 options to buy @ $11.99, valued at $1.7M
02/21/2023 4 FORD KATHLEEN (COO) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 185,000 options to buy @ $11.99, valued at $2.2M
02/21/2023 4 DALE STEPHEN (Chief Medical Officer) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 23,125 shares @ $0
Granted 185,000 options to buy @ $11.99, valued at $2.2M
02/21/2023 4 WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.
Txns: Disposed of 468,297 shares @ $0
Disposed of 17,708 shares @ $0
Disposed of 41,318 shares @ $0
Acquired 41,318 shares @ $0
Disposed of 1,084,300 shares @ $0
Acquired 1,084,300 shares @ $0
Disposed of 11,985 shares @ $0
Granted 560,000 options to buy @ $11.99, valued at $6.7M
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2022 4 Bair Teresa Brophy (Chief Legal Officer) has filed a Form 4 on Kura Oncology, Inc.
Txns: Sold 2,100 shares @ $15.2212, valued at $32k
06/23/2022 4 Collins Helen Louise (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 23,000 options to buy @ $14.84, valued at $341.3k
06/23/2022 4 SCHAFER CAROL (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 23,000 options to buy @ $14.84, valued at $341.3k
06/23/2022 4 Parks Diane L. (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 23,000 options to buy @ $14.84, valued at $341.3k
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2022 4 Stein Steven H (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 23,000 options to buy @ $14.84, valued at $341.3k
06/23/2022 4 Malley Thomas (Director) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 23,000 options to buy @ $14.84, valued at $341.3k
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2022 4 DOYLE THOMAS JAMES (SVP, Finance & Accounting) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 8,390 shares @ $0
Granted 39,281 options to buy @ $13.14, valued at $516.2k
02/09/2022 3 DOYLE THOMAS JAMES (SVP, Finance & Accounting) has filed a Form 3 on Kura Oncology, Inc.
01/28/2022 4 GRASSO MARC (CFO, CBO) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 21,900 shares @ $0
Granted 131,000 options to buy @ $14.15, valued at $1.9M
01/28/2022 4 FORD KATHLEEN (COO) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 21,900 shares @ $0
Granted 171,000 options to buy @ $14.15, valued at $2.4M
01/28/2022 4 FLOWERS KIRSTEN (Chief Commercial Officer) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 21,900 shares @ $0
Granted 171,000 options to buy @ $14.15, valued at $2.4M
01/28/2022 4 DALE STEPHEN (Chief Medical Officer) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 36,900 shares @ $0
Granted 261,000 options to buy @ $14.15, valued at $3.7M
01/28/2022 4 WILSON TROY EDWARD (President and CEO) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 495,000 options to buy @ $14.15, valued at $7M
10/19/2021 4 Bair Teresa Brophy (Chief Legal Officer) has filed a Form 4 on Kura Oncology, Inc.
Txns: Granted 192,000 options to buy @ $17.51, valued at $3.4M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy